DNA vaccines against enteric infections

被引：14
作者：
Herrmann, John E. [1 ]
机构：
[1] Tufts Univ, Sch Vet Med, Div Infect Dis, North Grafton, MA 01536 USA
来源：
VACCINE | 2006年 / 24卷 / 18期
关键词：
DNA vaccines; enteric diseases;
D O I：
10.1016/j.vaccine.2005.07.012
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The first DNA vaccines for prevention of infectious diseases were described in 1993 and have since been shown to generate protective humoral and cellular immune responses to numerous infectious agents. For enteric infections, protective immunity has been obtained with DNA vaccines against several enteric viral, bacterial, and parasitic agents. Inoculation of DNA vaccines has generally been by intramuscular injection or by gene gun delivery of vaccine DNA-coated gold microparticles into the skin. Administration of DNA vaccines by the oral route would target the vaccines to enteric mucosal tissues, as well as providing a convenient means for vaccine delivery. Orally administered plasmid DNAs encapsulated in polymeric microparticles or inserted in live bacterial vectors have been effective in animal models for rotavirus DNA vaccines and Listeria monocytogenes DNA vaccines, respectively. Human trials of enteric DNA vaccines have not been initiated, but trials of veterinary vaccines have shown promise. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3705 / 3708
页数：4
相关论文
共 38 条
  • [1] New vaccine strategies against enterotoxigenic Escherichia coli.: I:: DNA vaccines against the CFA/I fimbrial adhesin
    Alves, AMB
    Lásaro, MO
    Almeida, DF
    Ferreira, LCS
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (02) : 223 - 229
  • [2] Two-color corrugated quantum-well infrared photodetector for remote temperature sensing
    Chen, CJ
    Choi, KK
    Chang, WH
    Tsui, DC
    [J]. APPLIED PHYSICS LETTERS, 1998, 72 (01) : 7 - 9
  • [3] Cornell KA, 1999, J IMMUNOL, V163, P322
  • [4] Darji A, 2000, FEMS IMMUNOL MED MIC, V27, P341
  • [5] Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes
    Epstein, JE
    Gorak, EJ
    Charoenvit, Y
    Wang, RB
    Freydberg, N
    Osinowo, O
    Richie, TL
    Stoltz, EL
    Trespalacios, F
    Nerges, J
    Ng, J
    Fallarme-Majam, V
    Abot, E
    Goh, L
    Parker, S
    Kumar, S
    Hedstrom, RC
    Norman, J
    Stout, R
    Hoffman, SL
    [J]. HUMAN GENE THERAPY, 2002, 13 (13) : 1551 - 1560
  • [6] USE OF DNA ENCODING INFLUENZA HEMAGGLUTININ AS AN AVIAN INFLUENZA VACCINE
    FYNAN, EF
    ROBINSON, HL
    WEBSTER, RG
    [J]. DNA AND CELL BIOLOGY, 1993, 12 (09) : 785 - 789
  • [7] Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine
    Gaucher, D
    Chadee, K
    [J]. VACCINE, 2002, 20 (27-28) : 3244 - 3253
  • [8] DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice
    Henke, A
    Zell, R
    Stelzner, A
    [J]. ANTIVIRAL RESEARCH, 2001, 49 (01) : 49 - 54
  • [9] Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles
    Herrmann, JE
    Chen, SC
    Jones, DH
    Tinsley-Bown, A
    Fynan, EF
    Greenberg, HB
    Farrar, GH
    [J]. VIROLOGY, 1999, 259 (01) : 148 - 153
  • [10] Herrmann JE, 2003, PERSP MED V, V9, P369
1234